ストックスクリーナーアプリを入手
75.28
2.42%
1.89
前日終値:
$73.39
開ける：
$72.1
24時間の取引高:
724.79K
Relative Volume:
0.59
時価総額：
$10.09B
収益：
$2.48B
当期純損益:
$91.51M
株価収益率:
112.36
EPS:
0.67
ネットキャッシュフロー:
$293.77M
1週間 パフォーマンス:
+1.10%
1か月 パフォーマンス:
-6.42%
6か月 パフォーマンス:
+7.41%
1年 パフォーマンス:
+45.05%
1日の値動き範囲:
$71.73
$75.56
1週間の範囲:
$70.67
$75.56
52週間の値動き範囲:
$49.33
$94.93
Globus Medical Inc Stock (GMED) Company Profile
名前
Globus Medical Inc
セクター
電話
610-930-1800
住所
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
GMED を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
75.25 | 10.09B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
131.69 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.03 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.99 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.67 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.78 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-09-19 | アップグレード | Stifel | Hold → Buy |
| 2023-03-30 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-02-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-02-10 | ダウングレード | Loop Capital | Buy → Hold |
| 2023-02-10 | ダウングレード | Needham | Buy → Hold |
| 2023-02-10 | ダウングレード | Truist | Buy → Hold |
| 2023-02-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-28 | 開始されました | Wells Fargo | Overweight |
| 2022-01-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | アップグレード | BofA Securities | Underperform → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-10-29 | 開始されました | Loop Capital | Buy |
| 2021-02-18 | 再開されました | Needham | Buy |
| 2020-12-08 | 開始されました | Citigroup | Buy |
| 2020-10-20 | 開始されました | Stifel | Hold |
| 2020-08-06 | 繰り返されました | Needham | Buy |
| 2020-08-06 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | 開始されました | Northland Capital | Market Perform |
| 2020-07-06 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | 繰り返されました | Needham | Buy |
| 2020-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-12-12 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | 繰り返されました | Needham | Buy |
| 2019-05-24 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | 繰り返されました | Needham | Buy |
| 2019-02-28 | アップグレード | UBS | Neutral → Buy |
| 2019-01-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-27 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-05-03 | 繰り返されました | Needham | Buy |
| 2018-04-04 | アップグレード | Needham | Hold → Buy |
すべてを表示
Globus Medical Inc (GMED) 最新ニュース
Robotic-assisted Surgery Systems Market Set to Witness - openPR.com
Total Disc Replacement Market Future Business Opportunities - openPR.com
Levi & Korsinsky Reminds Shareholders of an Investigation into Globus Medical, Inc. (GMED) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Despite the downward trend in earnings at Globus Medical (NYSE:GMED) the stock grows 7.0%, bringing five-year gains to 80% - Yahoo Finance
Orthobiologics Market Future Business Opportunities - openPR
New Product Launches Benefit GMED Stock Amid Macro Issues - MSN
1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down - Yahoo Finance
GMED Stock Jumps 41.8% in a Year: What's Behind the Rally? - Yahoo Finance
Globus Medical (NYSE:GMED) shareholders notch a 11% CAGR over 5 years, yet earnings have been shrinking - simplywall.st
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
How Is The Market Feeling About Globus Medical? - Benzinga
Should You Hold Globus Medical Stock in Your Portfolio Now? - MSN
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Truist Financial Has Lowered Expectations for Globus Medical (NYSE:GMED) Stock Price - MarketBeat
Breaking Down Globus Medical: 5 Analysts Share Their Views - Benzinga
Stifel maintains Buy rating and $94 target on Globus Medical stock - Investing.com UK
Truist Cuts Price Target on Globus Medical to $82 From $90, Keeps Hold Rating -March 18, 2025 at 07:08 am EDT - MarketScreener
Interspinous Spacers Market Growth in Future Scope 2025-2032 | - openPR
Piper Sandler Sticks to Their Buy Rating for Globus Medical (GMED) - The Globe and Mail
Global Medical Handily Beats 2024 Sales Estimates - Orthopedics This Week
Globus Medical Expands Anterior Spine Portfolio With Two New Offerings - Yahoo Finance
Globus Medical Introduces Advanced Solutions for ALIF Surgery - MyChesCo
Globus Medical (NYSE:GMED) Stock Rating Upgraded by StockNews.com - Defense World
Globus Medical introduces new spine surgery solutions By Investing.com - Investing.com Canada
Globus Medical introduces new spine surgery solutions - Investing.com
Globus Medical Launches Innovative COHERE™ ALIF Spacer and Modulus™ ALIF Blades for Spine Surgery - Nasdaq
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio - Bluefield Daily Telegraph
Globus Medical extends versatility of Advanced Materials - GlobeNewswire
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades - Yahoo Finance
Hip Replacement Market Report and Company Analysis 2025-2033 Featuring Smith & Nephew, J&J, Integra, Zimmer Biomet, Stryker, B. Braun Melsungen, Globus Medical, MicroPort Scientific, Conformis - OrthoSpineNews
OsteoCentric Technologies Enters into a Non-Exclusive Licensing Agreement with Globus Medical - The Malaysian Reserve
Implantable Medical Devices Market growing at a CAGR of 7.2% from 2021 to 2030 | CONMED Corporation, Globus - EIN News
Hip Replacement Market Report and Company Analysis - GlobeNewswire
Medical Devices & SuppliesSpecialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers - Yahoo Finance
Globus Medical to Showcase Cutting-Edge Innovations at 2025 AAOS Meeting - MSN
Proficio Capital Partners LLC Buys Shares of 14,392 Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical to feature ExcelsiusFlex™ for Total Knee - GlobeNewswire
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting - The Manila Times
Globus Medical to Showcase Innovative Technologies at 2025 AAOS Annual Meeting in San Diego - Nasdaq
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of ... - Bluefield Daily Telegraph
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic - EIN News
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference - GlobeNewswire
Can Globus Medical's Conference Presentation Reveal New Growth Strategy? - StockTitan
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock? - MSN
There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings - Simply Wall St
Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Private Advisor Group LLC Boosts Stake in Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical Inc (GMED) 財務データ
収益
当期純利益
現金流量
EPS
0.44%
0.15%
大文字化:
|
ボリューム (24 時間):